IG RD 001
Alternative Names: IG-RD-001; Leucet; Petasites; Petasol butenoate; Petasol butenoate complex; Tesalin; ZE 339Latest Information Update: 06 Jun 2011
At a glance
- Originator Zeller
- Developer Indigene Pharmaceuticals; Zeller
- Class Antiallergics; Antimigraines; Phytotherapies
- Mechanism of Action Leukotriene inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Seasonal allergic rhinitis
Most Recent Events
- 31 Dec 2008 Discontinued - Phase-III for Seasonal allergic rhinitis in Germany (PO)
- 19 Sep 2003 Launched for Seasonal allergic rhinitis in Switzerland (PO)
- 02 Sep 2003 Registered for Seasonal allergic rhinitis in Switzerland (PO)